Literature DB >> 25187396

Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy.

Kathryn E Williams1, Nigel J Bundred, Göran Landberg, Robert B Clarke, Gillian Farnie.   

Abstract

Cancer stem cells (CSCs) can avoid or efficiently repair DNA damage from radio and chemotherapy, which suggests they play a role in disease recurrence. Twenty percentage of patients treated with surgery and radiotherapy for ductal carcinoma in situ (DCIS) of the breast recur and our previous data show that high grade DCIS have increased numbers of CSCs. Here, we investigate the role of focal adhesion kinase (FAK) and Wnt pathways in DCIS stem cells and their capacity to survive irradiation. Using DCIS cell lines and patient samples, we demonstrate that CSC-enriched populations are relatively radioresistant and possess high FAK activity. Immunohistochemical studies of active FAK in DCIS tissue show high expression was associated with a shorter median time to recurrence. Treatment with a FAK inhibitor or FAK siRNA in nonadherent and three-dimensional matrigel culture reduced mammosphere formation, and potentiated the effect of 2 Gy irradiation. Moreover, inhibition of FAK in vitro and in vivo decreased self-renewal capacity, levels of Wnt3a and B-Catenin revealing a novel FAK-Wnt axis regulating DCIS stem cell activity. Overall, these data establish that the FAK-Wnt axis is a promising target to eradicate self-renewal capacity and progression of human breast cancers.
© 2014 AlphaMed Press.

Entities:  

Keywords:  Breast; Cancer stem cells; Focal adhesion kinase; Radiotherapy; Spheres; Wnt

Mesh:

Substances:

Year:  2015        PMID: 25187396     DOI: 10.1002/stem.1843

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  28 in total

1.  BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.

Authors:  Mengdong Ni; Jiajia Li; Haiyun Zhao; Fei Xu; Jingyi Cheng; Min Yu; Guihao Ke; Xiaohua Wu
Journal:  Oncogene       Date:  2021-03-12       Impact factor: 9.867

2.  Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.

Authors:  Cindy Weidmann; Julie Bérubé; Léo Piquet; Arnaud de la Fouchardière; Solange Landreville
Journal:  Clin Exp Metastasis       Date:  2018-04-25       Impact factor: 5.150

3.  PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment.

Authors:  Ke Ma; Wan Fu; Ming Tang; Chaohua Zhang; Tianyun Hou; Ran Li; Xiaopeng Lu; Yanan Wang; Jingyi Zhou; Xue Li; Luyao Zhang; Lina Wang; Ying Zhao; Wei-Guo Zhu
Journal:  Autophagy       Date:  2017-01-19       Impact factor: 16.016

Review 4.  In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ.

Authors:  Ethan J Brock; Kyungmin Ji; Seema Shah; Raymond R Mattingly; Bonnie F Sloane
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-28       Impact factor: 2.673

5.  MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Authors:  Qianyu Guo; Vivian Z Li; Jessica N Nichol; Fan Huang; William Yang; Samuel E J Preston; Zahra Talat; Hanne Lefrère; Henry Yu; Guihua Zhang; Mark Basik; Christophe Gonçalves; Yao Zhan; Dany Plourde; Jie Su; Jose Torres; Maud Marques; Sara Al Habyan; Krikor Bijian; Frédéric Amant; Michael Witcher; Fariba Behbod; Luke McCaffrey; Moulay Alaoui-Jamali; Nadia V Giannakopoulos; Muriel Brackstone; Lynne-Marie Postovit; Sonia V Del Rincón; Wilson H Miller
Journal:  Cancer Res       Date:  2019-01-18       Impact factor: 12.701

Review 6.  Targeting FAK in anticancer combination therapies.

Authors:  John C Dawson; Alan Serrels; Dwayne G Stupack; David D Schlaepfer; Margaret C Frame
Journal:  Nat Rev Cancer       Date:  2021-03-17       Impact factor: 60.716

7.  Glial and Neuronal Protein Tyrosine Phosphatase Alpha (PTPα) Regulate Oligodendrocyte Differentiation and Myelination.

Authors:  Yuda Shih; Philip T T Ly; Jing Wang; Catherine J Pallen
Journal:  J Mol Neurosci       Date:  2017-06-24       Impact factor: 3.444

Review 8.  Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer.

Authors:  Evthokia A Hobbs; Natalie Chen; Alphi Kuriakose; Elizabeth Bonefas; Bora Lim
Journal:  Ther Adv Med Oncol       Date:  2022-07-16       Impact factor: 5.485

9.  Adaptive Resistance to Chemotherapy, A Multi-FAK-torial Linkage.

Authors:  Kristin N Taylor; David D Schlaepfer
Journal:  Mol Cancer Ther       Date:  2018-04       Impact factor: 6.261

Review 10.  Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal.

Authors:  Fabrizio Marcucci; Cristiano Rumio; François Lefoulon
Journal:  Front Oncol       Date:  2016-05-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.